U.S. Digital Therapeutics Market Size & Outlook, 2023-2030
U.S. digital therapeutics market, 2018-2030 (US$M)
Related Markets
U.S. digital therapeutics market highlights
- The U.S. digital therapeutics market generated a revenue of USD 2,152.3 million in 2023 and is expected to reach USD 10,491.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 25.4% from 2024 to 2030.
- In terms of segment, diabetes was the largest revenue generating application in 2023.
- Diabetes is the most lucrative application segment registering the fastest growth during the forecast period.
Digital therapeutics market data book summary
| Market revenue in 2023 | USD 2,152.3 million |
| Market revenue in 2030 | USD 10,491.4 million |
| Growth rate | 25.4% (CAGR from 2023 to 2030) |
| Largest segment | Diabetes |
| Fastest growing segment | Diabetes |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Cessation, CNS Diseases |
| Key market players worldwide | Omega Healthcare Investors Inc, Teladoc Health Inc, ResMed Inc, Fitbit, Mango Health, Akili Inc Ordinary Shares, Hygeia Healthcare Holdings Co Ltd Ordinary Shares, DarioHealth Corp, BioGaia AB Class B |
Other key industry trends
- In terms of revenue, U.S. accounted for 34.6% of the global digital therapeutics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. digital therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,942.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Digital Therapeutics Market Scope
Digital Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. digital therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital therapeutics market will help companies and investors design strategic landscapes.
Diabetes was the largest segment with a revenue share of 28.07% in 2023. Horizon Databook has segmented the U.S. digital therapeutics market based on diabetes, obesity, cvd, respiratory diseases, smoking cessation, cns diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing adoption of digital therapeutics is anticipated to play a major role in the future of healthcare by offering better options for treatment and management of various diseases, such as diabetes, asthma, & obesity.
For instance, in April 2021, Kaia Health, a smartphone-based chronic condition management startup, closed a USD 75 million Series C financing round. The company was expected to use this funding to increase its digital therapy for individuals dealing with musculoskeletal conditions and COPD.
Local presence of established players is further contributing to market growth in the country. These players are focused on constant innovation in their offerings as a means of strategic expansion. For instance, in June 2021, U.S. FDA allowed marketing of the first game-based digital therapeutic device.
Reasons to subscribe to U.S. digital therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. digital therapeutics market databook
-
Our clientele includes a mix of digital therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. digital therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. digital therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. digital therapeutics market size, by application, 2018-2030 (US$M)
U.S. Digital Therapeutics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
